These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19653788)

  • 1. Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
    Chopra MP; Landes RD; Gatchalian KM; Jackson LC; Buchhalter AR; Stitzer ML; Marsch LA; Bickel WK
    Exp Clin Psychopharmacol; 2009 Aug; 17(4):226-36. PubMed ID: 19653788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
    Gross A; Marsch LA; Badger GJ; Bickel WK
    Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
    Fiellin DA; Pantalon MV; Chawarski MC; Moore BA; Sullivan LE; O'Connor PG; Schottenfeld RS
    N Engl J Med; 2006 Jul; 355(4):365-74. PubMed ID: 16870915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.
    Kosten T; Poling J; Oliveto A
    Addiction; 2003 May; 98(5):665-71. PubMed ID: 12751984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M; Gonzalez G; Poling J; Kosten TR
    Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
    Oliveto A; Poling J; Sevarino KA; Gonsai KR; McCance-Katz EF; Stine SM; Kosten TR
    Drug Alcohol Depend; 2005 Aug; 79(2):157-65. PubMed ID: 16002025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
    Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
    Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
    Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
    Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of psychotherapy attendance on buprenorphine treatment outcome.
    Montoya ID; Schroeder JR; Preston KL; Covi L; Umbricht A; Contoreggi C; Fudala PJ; Johnson RE; Gorelick DA
    J Subst Abuse Treat; 2005 Apr; 28(3):247-54. PubMed ID: 15857725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
    Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH
    Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
    Gerra G; Fantoma A; Zaimovic A
    J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of time-based administration of abstinence reinforcement targeting opiate and cocaine use.
    Toegel F; Holtyn AF; Subramaniam S; Silverman K
    J Appl Behav Anal; 2020 Jul; 53(3):1726-1741. PubMed ID: 32249414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrice-weekly versus daily buprenorphine maintenance.
    Schottenfeld RS; Pakes J; O'Connor P; Chawarski M; Oliveto A; Kosten TR
    Biol Psychiatry; 2000 Jun; 47(12):1072-9. PubMed ID: 10862807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Silverman K
    J Appl Behav Anal; 2014; 47(4):681-93. PubMed ID: 25292399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Psychopharmacology (Berl); 1994 Dec; 116(4):401-6. PubMed ID: 7701040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended voucher-based reinforcement therapy for long-term drug abstinence.
    Carpenedo CM; Kirby KC; Dugosh KL; Rosenwasser BJ; Thompson DL
    Am J Health Behav; 2010; 34(6):776-87. PubMed ID: 20604701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.